| Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes F Olson, CA Hunt, FC Szoka, WJ Vail, D Papahadjopoulos Biochimica et Biophysica Acta (BBA)-Biomembranes 557 (1), 9-23, 1979 | 1374 | 1979 |
| In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom SB Noonberg, CA Hunt US Patent 5,624,803, 1997 | 481 | 1997 |
| Liposome disposition in vivo: III. Dose and vesicle-size effects RM Abra, CA Hunt Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism 666 (3), 493-503, 1981 | 323 | 1981 |
| Tolerance and disposition of tetrahydrocannabinol in man. CA Hunt, RT Jones Journal of Pharmacology and Experimental Therapeutics 215 (1), 35-44, 1980 | 271 | 1980 |
| Physicochemical properties, solubility, and protein binding of Δ9 ‐tetrahydrocannabinol ER Garrett, CA Hunt Journal of pharmaceutical sciences 63 (7), 1056-1064, 1974 | 263 | 1974 |
| Synthesis and evaluation of a prototypal artificial red cell CA Hunt, RR Burnette, RD MacGregor, AE Strubbe, DT Lau, N Taylor, ... Science 230 (4730), 1165-1168, 1985 | 198 | 1985 |
| Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration K Hirano, CA Hunt Journal of pharmaceutical sciences 74 (9), 915-921, 1985 | 173 | 1985 |
| Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme M Nikanjam, AR Gibbs, CA Hunt, TF Budinger, TM Forte Journal of controlled release 124 (3), 163-171, 2007 | 163 | 2007 |
| Glucose transport to the brain: a systems model AA Qutub, CA Hunt Brain research reviews 49 (3), 595-617, 2005 | 123 | 2005 |
| The metabolic disposition of radiolabeled enkephalins in vitro and in situ FB Craves, PY Law, CA Hunt, HH Loh Journal of Pharmacology and Experimental Therapeutics 206 (2), 492-506, 1978 | 116 | 1978 |
| Method for producing liposomes in selected size range CA Hunt, DP Papahadjopoulous US Patent 4,529,561, 1985 | 114 | 1985 |
| Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations CA Hunt, RD MacGregor, RA Siegel Pharmaceutical research 3 (6), 333-344, 1986 | 112 | 1986 |
| α-Tocopherol retards autoxidation and prolongs the shelf-life of liposomes CA Hunt, S Tsang International Journal of Pharmaceutics 8 (2), 101-110, 1981 | 111 | 1981 |
| Liposome disposition in vivo: effects of pre-dosing with lipsomes. RM Abra, ME Bosworth, CA Hunt Research communications in chemical pathology and pharmacology 29 (2), 349-360, 1980 | 93 | 1980 |
| Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis W Yu, X Fang, A Ewald, K Wong, CA Hunt, Z Werb, MA Matthay, K Mostov Molecular biology of the cell 18 (5), 1693-1700, 2007 | 92 | 2007 |
| At the biological modeling and simulation frontier CA Hunt, GEP Ropella, TN Lam, J Tang, SHJ Kim, JA Engelberg, ... Pharmaceutical research 26 (11), 2369-2400, 2009 | 89 | 2009 |
| Retention of cytosine arabinoside in mouse lung following intravenous administration in liposomes of different size. CA Hunt, YM Rustum, E Mayhew, D Papahadjopoulos Drug Metabolism and Disposition 7 (3), 124-128, 1979 | 88 | 1979 |
| Pharmacokinetics of Δ9-tetrahydrocannabinol in dogs ER Garrett, CA Hunt Journal of pharmaceutical sciences 66 (3), 395-407, 1977 | 86 | 1977 |
| Characteristics of oligonucleotide uptake in human keratinocyte cultures SB Noonberg, MR Garovoy, CA Hunt Journal of investigative dermatology 101 (5), 727-731, 1993 | 85 | 1993 |
| In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulation SB Noonberg, GK Scott, MR Garovoy, CC Benz, CA Hunt Nucleic acids research 22 (14), 2830-2836, 1994 | 80 | 1994 |
